Healthcare Subsector Review Part 2: Risky Seasonality Ahead but Plenty of Opportunities in Biotech
Healthcare Subsector Review Part 2-Opportunties in Biotech Stocks Healthcare stocks remain performance laggards YTD along with the energy sector. In the most recent quarter the top sectors are Technology, Industrials and Communication Services. Weakness in stock performance from most MEDtech...
Vacation This Week through Aug 1, 2025…Update-2 8/1
Vacation Week through Aug 1-Limited Postings Will update major biotech and earnings news. Will summarize healthcare subsectors at end of week. Update-1 7/29/25 2:42P EDT...Look for strength on a weak day like today: ABBV, INCY, RNA, VRTX. A new tax on PATENTS!? Has Howard Lutnick lost his...
Why are Healthcare stocks Underperforming the Market? Part I : A Brief Overview of the Subsectors…Update-2…Biotech rally is on
Update-2 7/23/25...10:45 a BIOTECH rally continues with ARKG and XBI up on a GREEN SCREEN DAY: Finally -- one of our new Trading LIST picks XENCOR (XNCR) shows Momentum at $9.80, undervalued with P/CASh. at 1.5,RSI is now soaring.,one new partnership will take the stock to $12. Thermo Fisher...
Large Cap Biopharma Fights the “Undertow” With Gains for the Week…Update-4…biotech rally day?
7/21...10:15a SMID biotech rally leads the way: ARKG at $26 and XBI. Watch for momentum continuing in: EYPT, COGT, MNMD, PACB, RXRX, XNCR-all longs 7/17/25.. 2.35P EDT...Calmer markets today with momentum coming back on selected SMID Biotechs: COGT, EYPT, MRUS, SLDB ,SUPG. XBI holding at $88...
Small Cap Biotechs: A Huge Opportunity for Traders and Investors…UPDATE-2…tariff talk!
Update-2 ...7/11/25...Momentum eases on tariiff threat with Canada. President Trump said tariffs on Canadian goods will go up to 35% next month. The market was at new highs on Thursday and this apparently gave Trump more leeway to launch stronger messages to our North American "trade partners"....